The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 14, 2019
Filed:
Aug. 24, 2017
Applicant:
Imprimis Pharmaceuticals, Inc., San Diego, CA (US);
Inventors:
John Scott Karolchyk, Lake Hopatcong, NJ (US);
Mark L. Baum, San Diego, CA (US);
Assignee:
IMPRIMIS PHARMACEUTICALS, INC., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/137 (2006.01); A61F 9/00 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 45/06 (2006.01); A61M 5/19 (2006.01); A61K 9/16 (2006.01); A61K 47/18 (2017.01); A61K 47/20 (2006.01); A61M 5/28 (2006.01); A61M 5/31 (2006.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A61F 9/0017 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 45/06 (2013.01); A61M 5/19 (2013.01); A61F 9/0008 (2013.01); A61K 9/1682 (2013.01); A61K 47/183 (2013.01); A61K 47/20 (2013.01); A61M 5/284 (2013.01); A61M 5/286 (2013.01); A61M 2005/3128 (2013.01);
Abstract
Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.